These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7526170)

  • 1. Series: current issues in mutagenesis and carcinogenesis, No. 51. Dose-level selection for in vivo genetic toxicity assays.
    Ashby J
    Mutat Res; 1994 Nov; 311(1):165. PubMed ID: 7526170
    [No Abstract]   [Full Text] [Related]  

  • 2. Regulatory requirement for three dose levels in rodent genetic toxicity assays.
    Galloway S
    Mutat Res; 1995 Jul; 329(2):213-9. PubMed ID: 7603503
    [No Abstract]   [Full Text] [Related]  

  • 3. International Workshop on Standardisation of Genotoxicity Test Procedures. Report of in vivo subgroup.
    Tice RR; Shelby MD
    Mutat Res; 1994 Jun; 312(3):287-92. PubMed ID: 7514740
    [No Abstract]   [Full Text] [Related]  

  • 4. Mammalian in vivo cytogenetic assays. Analysis of chromosome aberrations in bone marrow cells.
    Preston RJ; Dean BJ; Galloway S; Holden H; McFee AF; Shelby M
    Mutat Res; 1987 Oct; 189(2):157-65. PubMed ID: 3657831
    [No Abstract]   [Full Text] [Related]  

  • 5. Current issues in mutagenesis and carcinogenesis, No. 55. Activity of etoposide in the mouse bone marrow micronucleus test: independence of route of exposure.
    Ashby J; Tinwell H
    Mutat Res; 1995 May; 328(2):243-44. PubMed ID: 7739607
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of transgenic mouse lacI/Z mutation assays in genetic toxicology.
    Ashby J; Tinwell H
    Mutagenesis; 1994 May; 9(3):179-81. PubMed ID: 7934956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Series: 'Current issues in mutagenesis and carcinogenesis.' No. 43. Mutations among the living and the undead.
    Burkhart JG; Malling HV
    Mutat Res; 1994 Jan; 304(2):315-20. PubMed ID: 7506376
    [No Abstract]   [Full Text] [Related]  

  • 8. Recent findings concerning dose response relationship in mutagenicity testing of chemicals.
    Frohberg H; Schencking MS
    Arch Toxicol; 1974 Mar; 32(1):1-17. PubMed ID: 4134479
    [No Abstract]   [Full Text] [Related]  

  • 9. Dosimetry and acute toxicity of inhaled butadiene diepoxide in rats and mice.
    Henderson RF; Hahn FF; Benson JM; Barr EB; Bechtold WE; Burt DG; Dahl AR
    Toxicol Sci; 1999 Sep; 51(1):146-52. PubMed ID: 10496686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA damage and repair in somatic and germ cells in vivo.
    Vogel EW; Natarajan AT
    Mutat Res; 1995 Aug; 330(1-2):183-208. PubMed ID: 7623865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of phase specificity of in vivo germ cell mutagens in an in vitro germ cell system.
    Habas K; Anderson D; Brinkworth M
    Toxicology; 2016 Apr; 353-354():1-10. PubMed ID: 27059372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rodent carcinogenicity and toxicity, in vitro mutagenicity, and their physical chemical determinants.
    Benigni R; Andreoli C
    Mutat Res; 1993 Oct; 297(3):281-92. PubMed ID: 7692274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-ranging and dose-setting for in vivo genetic toxicology studies.
    Mackay JM; Elliott BM
    Mutat Res; 1992 Feb; 271(1):97-9. PubMed ID: 1371834
    [No Abstract]   [Full Text] [Related]  

  • 14. Guidelines for the conduct of micronucleus assays in mammalian bone marrow erythrocytes.
    MacGregor JT; Heddle JA; Hite M; Margolin BH; Ramel C; Salamone MF; Tice RR; Wild D
    Mutat Res; 1987 Oct; 189(2):103-12. PubMed ID: 3657826
    [No Abstract]   [Full Text] [Related]  

  • 15. The performance of short-term tests in identifying potential germ cell mutagens: a qualitative and quantitative analysis.
    Waters MD; Stack HF; Jackson MA; Bridges BA; Adler ID
    Mutat Res; 1994 Dec; 341(2):109-31. PubMed ID: 7527489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutagenicity trials under toxicological aspects.
    Frohberg H; Bauer A
    Arzneimittelforschung; 1973 Feb; 23(2):230-6. PubMed ID: 4573739
    [No Abstract]   [Full Text] [Related]  

  • 17. Series: 'Current issues in mutagenesis and carcinogenesis.' No. 42. Strategies and philosophies of genotoxicity testing: what is the question?
    Zeiger E
    Mutat Res; 1994 Jan; 304(2):309-14. PubMed ID: 7506375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxicology and carcinogenesis studies of p-nitrotoluene (CAS no. 99-99-0) in F344/N rats and B6C3F(1) mice (feed studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2002 May; (498):1-277. PubMed ID: 12118261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of carcinogenic and in vivo genotoxic potency estimates.
    Sanner T; Dybing E
    Basic Clin Pharmacol Toxicol; 2005 Feb; 96(2):131-9. PubMed ID: 15679476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxicology and carcinogenesis studies of o-nitrotoluene sulfone (CAS no. 88-72-2) in F344/N rats and B6C3F(1) mice (feed studies).
    National Toxicology Program, Public Health Service, National Institutes of Health, US Department of Health and Human Services
    Natl Toxicol Program Tech Rep Ser; 2002 May; (504):1-357. PubMed ID: 12087420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.